Synova's investment in InsurEvo is set to generate a significant return, driven by the company's impressive growth and innovative approach in the travel insurance market.

Target Information

InsurEvo, under the leadership of CEO Chris Rolland, has experienced remarkable growth since Synova's investment. The company has quintupled its revenues, reaching £60 million, while also placing £150 million in Gross Written Premium (GWP) into the market this year, a sixfold increase compared to the beginning of the investment period. This upward trajectory illustrates InsurEvo's robust performance in the insurance sector.

The significant enhancement in scale and profitability can largely be attributed to strategic investments in advanced technology, particularly in actuarial AI. By leveraging its unique data sets, InsurEvo has not only improved operational efficiency but has also developed innovative solutions tailored for diverse customer needs. The firm has provided coverage to over 4 million travelers, notably extending travel coverage options to individuals with pre-existing medical conditions.

Industry Overview

The travel insurance industry in the UK has seen considerable growth in recent years, driven by a rising number of international travelers and increased awareness of the importance o